ABPI "admonishes" Servier and Shire

25 March 2007

The Association of the British Pharmaceutical Industry's Code of Practice was breached by UK drugmaker Shire and Servier Laboratories, the local subsidiary of France's Servier Research Group, according to a statement by the Prescription Medicines Code of Practice Authority, which polices the ABPI's Code.

Servier was judged to have breached the Code by "using inappropriate material when training representatives on how to target hospital staff." The offences deemed to have been commited by the firm involved clause 2 "bringing disrepute upon, or reducing confidence in, the pharmaceutical industry;" clause 9.1 "failing to maintain a high standard;" and clause 15.9 "failing to make available appropriate briefing material to instruct representatives on how to engage with health professionals."

New member hit by Code

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight